AV‐optimized conduction system pacing for treatment of AV dromotropathy: A randomized, cross‐over study
Journal of Cardiovascular Electrophysiology · 2024
DOI: 10.1111/jce.16268 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2024. Verfasst von Anja Zupan Mežnar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Cross-Over Studies, Atrioventricular Block, Cardiac Pacing, Artificial, Ventricular Function, Left. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University Medical Center Ljubljana.
Abstract (Originalsprache)
Background
Severe first‐degree atrioventricular (AV) block may produce symptoms similar to heart failure due to AV dyssynchrony, a syndrome termed AV dromotropathy. According to guidelines, it should be considered for permanent pacemaker implantation, yet evidence supporting this treatment is scarce.
Objectives
This study aimed to determine the impact of AV‐optimized conduction system pacing (CSP) in patients with symptomatic severe first‐degree AV block and echocardiographic signs of AV dyssynchrony.
Methods
Patients with symptomatic first‐degree AV block (PR > 250 ms), preserved left ventricular ejection fraction, narrow QRS, and AV dyssynchrony were included in the study. In a single‐blind cross‐over design, patients were randomized to AV sequential CSP or backup VVI pacing with a base rate of 40 bpm. We compared exercise capacity, echocardiographic parameters, and symptom occurrence at the end of 3 months of each period.
Results
Fourteen patients completed the study. During the AV‐optimized CSP compared to the backup pacing period, patients achieved a higher workload on exercise test (147.2 ± 50.9 vs. 140.7 ± 55.8 W; p = .032), with a trend towards higher peak VO2 (23.3 ± 7.1 vs. 22.8 ± 7.1 mL/min/kg; p = .224), and higher left ventricular stroke volume (LVSV 74.5 ± 13.8 vs. 66.4 ± 12.5 mL; p < .001). Symptomatic improvement was recorded, with fewer patients reporting general tiredness and 71% of patients preferring the AV‐optimized CSP ( p = .008).
Conclusions
AV‐optimized CSP could improve symptoms, exercise capacity and LVSV in patients with severe first‐degree AV block.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, University Medical Center Ljubljana, Ljubljana, Slovenia.
- Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
- Faculty of Medicine and Life Sciences, University Hasselt, Hasselt, Belgium.
- Department of Cardiovascular Surgery, University Medical Center Ljubljana, Ljubljana, Slovenia.
ORCID-Profile: Anja Zupan Mežnar, Miha Mrak, David Žižek
Förderung
- University Medical Center Ljubljana
Zitieren
APA
Zupan Mežnar, A., Mrak, M., Mullens, W., Štublar, J., Ivanovski, M., & Žižek, D. (2024). AV‐optimized conduction system pacing for treatment of AV dromotropathy: A randomized, cross‐over study. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16268
Vancouver
Zupan Mežnar A, Mrak M, Mullens W, Štublar J, Ivanovski M, Žižek D. AV‐optimized conduction system pacing for treatment of AV dromotropathy: A randomized, cross‐over study. Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16268
BibTeX
@article{ZupanMenar2024,
author = {Zupan Mežnar, Anja and Mrak, Miha and Mullens, Wilfried and Štublar, Jernej and Ivanovski, Maja and Žižek, David},
title = {AV‐optimized conduction system pacing for treatment of AV dromotropathy: A randomized, cross‐over study},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2024},
doi = {10.1111/jce.16268}
}
EUVIMED